Bonadeo F A, Vaccaro C A, Benati M L, Quintana G M, Garione X E, Telenta M T
Department of Surgery, Hospital Italiano, Buenos Aires, Argentina.
Dis Colon Rectum. 2001 Mar;44(3):374-9. doi: 10.1007/BF02234736.
This study was designed to assess the local recurrence rate and prognostic factors for local recurrence in patients undergoing curative anterior or abdominoperineal resections without radiotherapy.
From January 1980 to December 1996, 514 consecutive patients underwent curative resections for rectal cancer. We excluded those with preoperative radiotherapy (n = 23), postoperative radiotherapy (n = 27), local resection (n = 36), and 11 (2.1 percent) patients who died postoperatively. The remaining 417 patients (249 males) with a median age of 64 (range, 21-90) years were analyzed. For upper third lesions, mesorectal tissue was excised down to at least 5 cm below the tumor. Total mesorectal excision was performed for lower and middle tumors. Postoperative chemotherapy was limited to patients with Stage III lesions. Median follow-up (and 95 percent confidence interval) was (5.2 4.3-5.9) years, with 87.7 percent of patients followed up longer than 24 months. Local recurrence was defined as any recurrence within the field of resection, regardless of the presence or absence of distant metastasis.
Five-year local recurrence rate(and 95 percent confidence interval) was 9.7 (6.4-13) percent, with a median time to diagnosis of 15 (10-23) months. Local recurrence rates in Stages I, II, and III were: 3.1, 4.1, and 24.1 percent, respectively (P < 0.0001). In relation to node status, local recurrence rates were N0, 4.1 (1.7-6.5) percent; N1, 12.6 (4.6-20.6) percent; N2, 32.1 (12.1-52.1) percent; and N3, 59.3 (22.5-96.1) percent; (P < 0.00001). Lower third tumors had a higher local recurrence rate than middle and upper third tumors: 17.9, 7.1, and 5.1 percent, respectively (P = 0.002). Adjusted by stage, this difference was maintained only in Stage III tumors. Among lower tumors, those at 6 and 7 cm from the anal verge had a lower local recurrence rate than those below 6 cm (6.7 vs. 26.2 percent, respectively; P = 0.02). Accidental rectal perforation at or near the tumor site occurred in 12 cases (2.9 percent), showing a strong correlation with local recurrence (P < 0.0001). Multivariate analysis showed significant higher risk for lower third tumors (hazard ratio, 2.98) and positive nodes (hazard ratio, 4.78).
Appropriate surgery without irradiation achieves excellent local control in N0 rectal cancers. Node metastasis, lower third localization (especially below 6 cm), and accidental rectal perforation at or near the tumor site are significantly associated with a higher local recurrence rate.
本研究旨在评估接受根治性前切除术或腹会阴联合切除术且未接受放疗的患者的局部复发率及局部复发的预后因素。
1980年1月至1996年12月,514例连续患者接受了直肠癌根治性切除术。我们排除了术前放疗患者(n = 23)、术后放疗患者(n = 27)、局部切除术患者(n = 36)以及11例(2.1%)术后死亡患者。对其余417例患者(249例男性)进行分析,中位年龄为64岁(范围21 - 90岁)。对于上段肿瘤,直肠系膜组织切除至肿瘤下方至少5 cm处。对于下段和中段肿瘤行全直肠系膜切除术。术后化疗仅限于Ⅲ期病变患者。中位随访时间(及95%置信区间)为(5.2 4.3 - 5.9)年,87.7%的患者随访时间超过24个月。局部复发定义为切除野内的任何复发,无论有无远处转移。
5年局部复发率(及95%置信区间)为9.7%(6.4 - 13%),诊断的中位时间为15个月(10 - 23个月)。Ⅰ期、Ⅱ期和Ⅲ期的局部复发率分别为:3.1%、4.1%和24.1%(P < 0.0001)。根据淋巴结状态,局部复发率分别为:N0,4.1%(1.7 - 6.5%);N1,12.6%(4.6 - 20.6%);N2,32.1%(12.1 - 52.1%);N3,59.3%(22.5 - 96.1%);(P < 0.00001)。下段肿瘤的局部复发率高于中段和上段肿瘤:分别为17.9%、7.1%和5.1%(P = 0.002)。按分期调整后,这种差异仅在Ⅲ期肿瘤中存在。在下段肿瘤中,距肛缘6 cm和7 cm处的肿瘤局部复发率低于距肛缘6 cm以下的肿瘤(分别为6.7%和26.2%;P = 0.02)。肿瘤部位或其附近的意外直肠穿孔发生12例(2.9%),与局部复发密切相关(P < 0.0001)。多因素分析显示下段肿瘤(风险比,2.98)和阳性淋巴结(风险比,4.78)的风险显著更高。
未行放疗的合适手术在N0期直肠癌中可实现良好的局部控制。淋巴结转移、下段定位(尤其是距肛缘6 cm以下)以及肿瘤部位或其附近的意外直肠穿孔与较高的局部复发率显著相关。